August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Sarah Sammons Highlights 77% Response Rate with Carboplatin, Bevacizumab, and PD-1 Inhibitors in TNBC Brain Metastases
May 31, 2025, 13:44

Sarah Sammons Highlights 77% Response Rate with Carboplatin, Bevacizumab, and PD-1 Inhibitors in TNBC Brain Metastases

Sarah Sammons, Breast Medical Oncologist and Senior Physician at Dana-Farber’s Breast Oncology Center, shared a post on X:

“Building off of Nancy Lin and Dr Pablo Leone’s data with carboplatin/bevacizumab in brain metastases.
77% intracranial response rate of carbo, bev, and PD-1 inhibition in TNBC brain metastases shows excellent potential.
Time to try this with bispecifics.”

Sarah Sammons

More posts featuring ASCO25.